Iodine nutrition status in Spain Needs for the future

Autor: Vila, L, Lucas, A, Donnay, S, de la Vieja, A, Wengrovicz, S, Santiago, P, Bandres, O, Velasco, I, Garcia-Fuentes, E, Ares, S, Navarro, JCM, Espada, M, Munoz, A, Galofre, JC, Puig-Domingo, M

Publikováno v: Endocrinologia Diabetes y Nutricion
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Although iodine nutrition in Spain has improved in recent years, the problem is not completely resolved. It is necessary that health institutions establish measures to ensure an adequate iodine nutrition of the population, especially among the highes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::35342ac7f5aa85edbf0d79ca4c539554
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1237

Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma

Autor: Jimenez-Fonseca, P, Saez, JMG, Sandi, JS, Capdevila, J, Gonzalez, EN, Llopis, CZ, Asensio, TRYC, Riesco-Eizaguirre, G, Grande, E, Galofre, JC

Publikováno v: Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Anaplastic thyroid cancer (ATC) is the most aggressive solid tumor and almost uniformly lethal in humans. The Boards of the Thyroid Cancer Group of the Spanish Society of Endocrinology and Nutrition and the Grupo Espaol de Enfermedades Hu,rfanas e In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4e60f8198b6f00517d29284767023462
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6815

Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI)

Autor: Capdevila, J, Galofre, JC, Grande, E, Llopis, CZ, Asensio, TRYC, Gonzalez, EN, Jimenez-Fonseca, P, Sandi, JS, Saez, JMG, Eizaguirre, GR

Publikováno v: Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)

Thyroid cancer is the single most prevalent endocrine malignancy; differentiated thyroid cancer (DTC) accounts for more than 90 % of all malignancies and its incidence has been rising steadily. For more patients, surgical treatment, radioactive iodin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3046e27e9d2f21d6eceec30cd70fe174
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6612

Pancreatic cancer escape variants that evade immuno-gene therapy through loss of sensitivity to IFN-gamma induced apoptosis

Autor: Mazzolini, G., Narvaiza, I., Martinez-Cruz, A., Arina, A., Barajas, M., Galofre, Jc, Qian, C., José Mato, Prieto, J., Melero, I.

Publikováno v: ResearcherID
Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::909d65673625080f4352e3b2b09df8fc
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000182740300311&KeyUID=WOS:000182740300311

Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results.

Autor: Sandúa A; Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain., Macias M; Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain., Perdomo C; Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain., Galofre JC; Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Spain., Ferrer R; Hospital Universitario Vall d'Hebron, Barcelona, Spain., Alegre E; Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Spain., González Á; Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Spain.

Publikováno v: Advances in laboratory medicine [Adv Lab Med] 2020 Jan 07; Vol. 1 (1), pp. 20190017. Date of Electronic Publication: 2020 Jan 07 (Print Publication: 2020).